MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

about

A Novel Whole Gene Deletion of BCKDHB by Alu-Mediated Non-allelic Recombination in a Chinese Patient With Maple Syrup Urine Disease.

P2860

Q55315671-63EF82D8-BC9D-4C07-9BE3-C1531294993E

P2860

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

Item

http://www.wikidata.org/entity/Q41699171

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

@en

type

Item

label

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

@en

prefLabel

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

@en

P1476

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

@en

P2093

Ailan Cheng

http://www.w3.org/2001/XMLSchema#string

Biao Jin

http://www.w3.org/2001/XMLSchema#string

Dengbin Wang

http://www.w3.org/2001/XMLSchema#string

Huimin Li

http://www.w3.org/2001/XMLSchema#string

Lianshu Han

http://www.w3.org/2001/XMLSchema#string

Rong Yao

http://www.w3.org/2001/XMLSchema#string

Yun Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.

MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.

Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.

Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.

Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Classical maple syrup urine disease and brain development: principles of management and formula design

Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease

E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.

Maple syrup urine disease: it has come a long way.

Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.

P304

398-402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/DIR.2017.16466

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28830848

http://www.w3.org/2001/XMLSchema#string

P932

5602367

http://www.w3.org/2001/XMLSchema#string

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

about

P2860

P2860

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932